Accessibility help Skip to navigation Skip to content Skip to footer

FT Series

Opioids and the Sackler family

The billionaire Sackler family and its company, Purdue Pharma, are named in lawsuits alleging their marketing tactics helped get a nation hooked on painkillers. The FT’s David Crow investigates

© Reuters

How Purdue’s ‘one-two’ punch fuelled the opioids market

Accused of exaggerating the benefits of OxyContin, the company’s owners had a bigger share than realised

Purdue Pharma's 'one-two' punch

The FT’s David Crow explains how the Sackler family company got its hold on the opioid market

What next for the Sacklers? A pharma dynasty under siege

An investigation into the unfolding scandal of a company accused of fuelling America’s opioid crisis

Billionaire Sackler family owns second opioid maker

Purdue owners set up Rhodes Pharma after criminal charges in 2007

Opioid billionaire gets patent for addiction treatment

Purdue owner Richard Sackler listed as inventor of drug to wean addicts off painkillers